Organon & Co (OGN)
17.86
-0.01
(-0.06%)
USD |
NYSE |
Apr 18, 16:00
17.75
-0.11
(-0.62%)
Pre-Market: 07:14
Organon Total Assets (Quarterly): 12.06B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.06B |
| September 30, 2023 | 11.01B |
| June 30, 2023 | 10.98B |
| March 31, 2023 | 10.76B |
| December 31, 2022 | 10.96B |
| September 30, 2022 | 10.44B |
| June 30, 2022 | 10.61B |
| Date | Value |
|---|---|
| March 31, 2022 | 10.60B |
| December 31, 2021 | 10.68B |
| September 30, 2021 | 11.34B |
| June 30, 2021 | 10.91B |
| March 31, 2021 | 9.642B |
| December 31, 2020 | 10.11B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.642B
Minimum
Mar 2021
12.06B
Maximum
Dec 2023
10.78B
Average
10.76B
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Merck & Co Inc | 106.68B |
| Alnylam Pharmaceuticals Inc | 3.830B |
| Biogen Inc | 26.84B |
| Pacira BioSciences Inc | 1.574B |
| Amphastar Pharmaceuticals Inc | 1.513B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.13B |
| Shareholders Equity (Quarterly) | -70.00M |
| Debt to Equity Ratio | -125.14 |
| Current Ratio | 1.545 |
| Net Debt Paydown Yield | -0.33% |